Lianbio
LIANY
$0.20
$0.0052.56%
OTC PK
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 68.89M | 67.90M | 66.86M | 67.81M | 62.64M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 106.56M | 104.81M | 122.91M | 125.35M | 118.14M |
Operating Income | -106.56M | -104.81M | -122.91M | -125.35M | -118.14M |
Income Before Tax | -87.11M | -85.55M | -106.51M | -110.62M | -114.23M |
Income Tax Expenses | 874.00K | 294.00K | 99.00K | -333.00K | -1.02M |
Earnings from Continuing Operations | -87.98 | -85.84 | -106.61 | -110.29 | -113.21 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -87.98M | -85.84M | -106.61M | -110.29M | -113.21M |
EBIT | -106.56M | -104.81M | -122.91M | -125.35M | -118.14M |
EBITDA | -105.26M | -103.55M | -121.85M | -124.35M | -117.21M |
EPS Basic | -0.82 | -0.80 | -0.99 | -1.02 | -1.13 |
Normalized Basic EPS | -0.51 | -0.50 | -0.62 | -0.65 | -0.72 |
EPS Diluted | -0.82 | -0.80 | -0.99 | -1.02 | -1.13 |
Normalized Diluted EPS | -0.51 | -0.50 | -0.62 | -0.65 | -0.72 |
Average Basic Shares Outstanding | 429.62M | 430.81M | 431.57M | 431.68M | 399.03M |
Average Diluted Shares Outstanding | 429.62M | 430.81M | 431.57M | 431.68M | 399.03M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |